Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D07WFK
|
||||
Former ID |
DAP000922
|
||||
Drug Name |
Acetohexamide
|
||||
Synonyms |
Acetohexamid; Acetohexamida; Acetohexamidum; Dimelin; Dimelor; Dymelor; Gamadiabet; Hypoglicil; Metaglucina; Minoral; Ordimel; Tsiklamid; Acetohexamide Lilly Brand; Acetohexamide Salvat Brand; Lilly Brand of Acetohexamide; Ord imel; Salvat Brand of Acetohexamide; U 14812; A-178; Acetohexamida [INN-Spanish]; Acetohexamidum [INN-Latin]; Dimelin (antidiabetic); Dymelor (TN); U-14812; Acetohexamide (JP15/USP/INN); Acetohexamide [USAN:INN:BAN:JAN]; N-(p-Acetylbenzenesulfonyl)-N'-cyclohexylurea; N-(p-Acetylphenylsulfonyl)-N'-cyclohexylurea; 1-((p-Acetylphenyl)sulfonyl)-3-cyclohexylurea; 1-(4-acetylphenyl)sulfonyl-3-cyclohexylurea; 1-(p-Acetylbenzenesulfonyl)-3-cyclohexylurea; 3-cyclohexyl-1-(p-acetylphenylsulfonyl)urea; 4-Acetyl-N-((cyclohexylamino)carbonyl)benzenesulfonamide; 4-Acetyl-N-[(cyclohexylamino)-carbonyl]benzenesulfonamide; 4-Acetyl-N-[(cyclohexylamino)carbonyl]benzenesulfonamide; 4-acetyl-N-((cyclohexylamino)carbonyl)benzenesulf onamide
|
||||
Drug Type |
Small molecular drug
|
||||
Therapeutic Class |
Hypoglycemic Agents
|
||||
Structure |
Download2D MOL |
||||
Formula |
C15H20N2O4S
|
||||
InChI |
InChI=1S/C15H20N2O4S/c1-11(18)12-7-9-14(10-8-12)22(20,21)17-15(19)16-13-5-3-2-4-6-13/h7-10,13H,2-6H2,1H3,(H2,16,17,19)
|
||||
InChIKey |
VGZSUPCWNCWDAN-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 968-81-0
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
9025, 4560832, 7847286, 8144406, 8151368, 10321105, 11110689, 11112460, 11466083, 11467203, 11485866, 15347370, 17390067, 17404651, 24278077, 26752942, 29221177, 46505821, 47216939, 47440426, 47662475, 47810929, 48185152, 48413134, 48415505, 48422764, 48424779, 49698323, 49856121, 50105548, 50105549, 50271749, 53777194, 56463352, 57321086, 57653828, 85083217, 85230885, 85787831, 90341130, 92125175, 92303511, 92307991, 99222786, 103590218, 103913586, 104171099, 104299291, 121360822, 121362846
|
||||
ChEBI ID |
ChEBI:28052
|
||||
SuperDrug ATC ID |
A10BB31
|
||||
Target and Pathway | |||||
Target(s) | Sulfonylurea receptor 1 | Target Info | Modulator | ||
Pathway Interaction Database | FOXA2 and FOXA3 transcription factor networks | ||||
PathWhiz Pathway | Muscle/Heart Contraction | ||||
Pancreas Function | |||||
WikiPathways | Potassium Channels | ||||
Integration of energy metabolism | |||||
References | |||||
Ref 538241 | FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 071893. | ||||
Ref 541874 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6793). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.